Add time:07/15/2019         Source:sciencedirect.com

We report the discovery of a novel series of 2-(3-alkoxy-1-azetidinyl) quinolines as potent and selective PDE10A inhibitors. Structure–activity studies improved the solubility (pH 7.4) and maintained high PDE10A activity compared to initial lead compound 3, with select compounds demonstrating good oral bioavailability. X-ray crystallographic studies revealed two distinct binding modes to the catalytic site of the PDE10A enzyme. An ex vivo receptor occupancy assay in rats demonstrated that this series of compounds covered the target within the striatum.

We also recommend Trading Suppliers and Manufacturers of 1-Azetidin-3-yl-piperidine (cas 138022-86-3). Pls Click Website Link as below: cas 138022-86-3 suppliers